FDA Inspection
Sawai Pharmaceutical Co., Ltd.Sawai Pharmaceutical Co., Ltd. – FDA Inspection, Oct 15, 2019
Record Details
This FDA Inspection record concerns Sawai Pharmaceutical Co., Ltd., with an inspection on October 15, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- October 15, 2019
- Product Type
- Drugs
View Company Profile
ID · 27989463-7102-4c50-b7b9-dc032e92e4fa
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1106656
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
4- 21 CFR 211.165(d)Acceptance criteria for sampling & testing
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Sawai Pharmaceutical Co., Ltd.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| August 30, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Sawai Pharmaceutical Co., Ltd.
- FDA Inspection 989053 - 2016-08-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.